# K252972: CARTO™ 3 EP Navigation System V8.4

- Pathway: 510(k) (Traditional)
- Applicant: Biosense Webster, Inc.
- Decided: Feb 20, 2026 after 156 days
- Product code: DQK (Computer, Diagnostic, Programmable)
- Device class: 2
- Regulation: 21 CFR 870.1425
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 20 generations back to K001437 (2000). 31 ancestors in all.
No later device cites it as a predicate yet.
0 of 32 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K252302: CARTO™ 3 EP Navigation System V8.1, Biosense Webster, Inc. (2025) Summary page 5.

## Indications for use
The intended use of the CARTOTM 3 System is catheter-based cardiac electrophysiological (EP) procedures. The CARTOTM 3 System provides information about the electrical activity of the heart and about catheter location during the procedure. The system can be used on patients who are eligible for a conventional electrophysiological procedure. The system has no special contraindications.

Source page: https://510kreport.com/device/K252972
Methodology: https://510kreport.com/methodology